Pharmstandard logo

Pharmstandard

Europe, Moscow City, Russian Federation, Moscow

Description

Pharmstandard is a pharmaceutical company that develops and manufactures modern pharmaceutical products.

Investor Profile

Pharmstandard has made 13 investments, with 0 in the past 12 months and 62% as lead.

Stage Focus

  • Series B (38%)
  • Private Equity (8%)
  • Series D (8%)
  • Debt Financing (8%)
  • Series C (8%)
  • Series E (8%)
  • Post Ipo Equity (8%)
  • Seed (8%)
  • Convertible Note (8%)

Country Focus

  • United States (77%)
  • Canada (8%)
  • Australia (8%)
  • Russian Federation (8%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Medical
  • Therapeutics
  • Eyewear
  • Genetics
  • Medical Device
  • Service Industry
  • Wellness
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Pharmstandard frequently co-invest with?

Omega Funds
Europe, Geneve, Switzerland, Geneva
Co-Investments: 1
Nextech Invest
Europe, Zurich, Switzerland, Zürich
Co-Investments: 1
CA
North America, Massachusetts, United States, Boston
Co-Investments: 1
Casdin Capital
North America, New York, United States, New York
Co-Investments: 1
VT
North America, Virginia, United States, Roanoke
Co-Investments: 2
Inbio Ventures
Europe, Moscow City, Russian Federation, Moscow
Co-Investments: 8
Intersouth Partners
North America, North Carolina, United States, Durham
Co-Investments: 2
Foresite Capital
North America, California, United States, San Francisco
Co-Investments: 1
Bessemer Venture Partners
North America, California, United States, San Francisco
Co-Investments: 2
Redmile Group
North America, California, United States, San Francisco
Co-Investments: 1

What are some of recent deals done by Pharmstandard?

TearSolutions

Charlottesville, Virginia, United States

TearSolutions is a pharmaceutical company that specializes in providing medical solutions for dry eyes.

EyewearMedicalPharmaceutical
Debt FinancingMar 21, 2019
Amount Raised: $6,400,000
TearSolutions

Charlottesville, Virginia, United States

TearSolutions is a pharmaceutical company that specializes in providing medical solutions for dry eyes.

EyewearMedicalPharmaceutical
Series BDec 7, 2017
Amount Raised: $8,500,000
Viriom

San Diego, California, United States

Viriom is a clinical and commercial stage biotech developing drugs for treatment, prevention and cure of HIV and other infections.

BiotechnologyHealth CarePharmaceutical
Convertible NoteDec 6, 2017
Amount Raised: $12,500,000
Genotek

Moscow, Moscow City, Russian Federation

Leading Russian Genetic Testing Company

BioinformaticsClinical TrialsGeneticsHealth Care
SeedFeb 17, 2017
Amount Raised: $1,000,000
Avelas Biosciences

La Jolla, California, United States

Avelas Biosciences develops real-time luminous maps for oncologic surgeons to refer while in surgery.

BiotechnologyLife ScienceReal Time
Series CAug 18, 2016
Amount Raised: $20,000,000
TransMedics

Andover, Massachusetts, United States

TransMedics provides technology and clinical service solutions.

Health CareMedicalMedical DeviceService IndustryWellness
Private EquityJul 12, 2016
Amount Raised: $12,500,000
Argos Therapeutics

Durham, North Carolina, United States

Argos Therapeutics develops immunotherapy treatments for cancers, infectious and autoimmune diseases, and transplantation rejection.

BiotechnologyHealth CareTherapeutics
Post Ipo EquityMar 15, 2016
Amount Raised: $60,000,000
Jounce Therapeutics

Cambridge, Massachusetts, United States

Jounce Therapeutics is developing cancer immune-therapies to harness the immune system to attack cancerous cells and tumors.

BiotechnologyPharmaceuticalTherapeutics
Series BApr 23, 2015
Amount Raised: $56,000,000
enGene

Vancouver, British Columbia, Canada

enGene is a biotechnology company develops treatment for mucosal diseases through inducing therapeutic proteins of harmful proteins.

BiotechnologyDiabetesGeneticsHealth Care
Series BJan 26, 2015
Amount Raised: $11,500,000
Allena Pharmaceuticals

Newton, Massachusetts, United States

Allena Pharmaceuticals develops and commercializes non-systemic protein therapeutics to treat metabolic and orphan diseases.

BiotechnologyPharmaceuticalTherapeutics
Series BDec 4, 2014
Amount Raised: $25,000,000